search
Back to results

Comparison of Strategies Based on RT-PCR or Antigenic Test for the Screening of SARS-CoV-2 Infection (COVID-19). (AutoCoV)

Primary Purpose

SARS-CoV Infection

Status
Completed
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
saliva sample combined to an anterior nare self-swabbing (Self-samples)
saliva sample (Self-sample)
Survey of SARS-COV-19 knowledge
Survey of acceptability of the different self-samples.
Sponsored by
Centre Hospitalier Universitaire de Saint Etienne
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for SARS-CoV Infection focused on measuring Covid19, RT-PCR, rapid antigenic test, SARS-CoV-2, self-sampling, diagnosis, mass screening, isolation measures, health education

Eligibility Criteria

10 Years - undefined (Child, Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Adult age or at least 10 year old able to perform self-sampling of saliva and anterior nare swabbing
  • Subject or legal tutor agreeing to participate to self-sampling and to collect anonymized data required by the present research

Exclusion Criteria:

  • Inability to understand the protocol (language barrier notably)
  • Deny to participate to the proposed research
  • Patients under tutorship

Sites / Locations

  • CHU Saint-Etienne

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

mass screening SARS-COV-19

Arm Description

20 0000 participant will be included during mass screening SARS-COV-19 of the population of the city of Saint-Etienne. They will have two strategies both based on self-samples: (i) a saliva sample combined to an anterior nare self-swabbing tested by antigenic test versus (ii) a saliva sample tested by RT-PCR.

Outcomes

Primary Outcome Measures

Positivity of self-samples combining saliva and anterior nare specimens tested by rapid antigenic test compared to saliva tested by RT-PCR (gold-standard).
Measured by antigenic test results and RT-PCR results.

Secondary Outcome Measures

Number and percentage of SARS-CoV-2 infection in the selected population tested by reference RT-PCR on saliva
Measured by RT-PCR results.
Number and percentage of the circulation of different variants of interest of SARS-CoV-2 viruses in the tested population
Measured by RT-PCR results.
Evaluate the acceptability (pain, discomfort, speed of execution) of self-samples according to age and socio-professional categories
Measured by survey of acceptability of the different self-samples results.
Evaluate the cost-effectiveness ratio of the new strategy by comparison to the gold standard (RT-PCR on saliva)
Measured by number of test performed and performances of self-samples combining saliva and anterior nare specimens tested by rapid antigenic test compared to saliva tested by RT-PCR.
Number of people who have benefited from sensitization and support specifically set up as part of the screening campaign
Measured the screening day.
Number of persons cared for by the territorial isolation support cell (CTAI)
Measured the screening day.
Health literacy questionnaire
It is a questionnaire with items on the transmission of the virus and barrier gestures, adherence to barrier gestures, modalities of isolation in case of positivity and motivations for participating in this screening campaign.

Full Information

First Posted
April 22, 2021
Last Updated
May 3, 2021
Sponsor
Centre Hospitalier Universitaire de Saint Etienne
search

1. Study Identification

Unique Protocol Identification Number
NCT04859023
Brief Title
Comparison of Strategies Based on RT-PCR or Antigenic Test for the Screening of SARS-CoV-2 Infection (COVID-19).
Acronym
AutoCoV
Official Title
Comparison of Strategies Based on RT-PCR or Antigenic Test for the Screening of SARS-CoV-2 Infection in General Population Using Self-samples (COVID-19).
Study Type
Interventional

2. Study Status

Record Verification Date
May 2021
Overall Recruitment Status
Completed
Study Start Date
February 22, 2021 (Actual)
Primary Completion Date
February 28, 2021 (Actual)
Study Completion Date
February 28, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Centre Hospitalier Universitaire de Saint Etienne

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The virological diagnosis of SARS-CoV-2 infection is pivotal for the control of the outbreak by large screening of a- or pauci-symptomatic subjects. Despite nasopharyngeal swabbing tested by RT-PCR is considered as the gold standard, new strategies based on self-samples are considered as valuable alternatives because of their non-invasiveness and ability to be performed in the absence healthcare worker, especially when the subject is asymptomatic and needs to be tested repetitively. The aim of the present project is to evaluate two strategies both based on self-samples: (i) a saliva sample combined to an anterior nare self-swabbing tested by antigenic test versus (ii) a saliva sample tested by RT-PCR. The comparison will be performed during a mass screening of the population of the city of Saint-Etienne (170000 inhabitants), France. The sensitivity of the rapid antigenic test will be evaluated in comparison to that of RT-PCR considered as gold standard.
Detailed Description
The main objective is to evaluate the performance of a strategy for screening for CoV-2-SARS infection that would combine 1) a salivary self-sample with an anterior nasal swab and 2) a diagnostic antigenic test, in comparison with the reference salivary RT-PCR technique recently validated by National Authority for Health (HAS).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
SARS-CoV Infection
Keywords
Covid19, RT-PCR, rapid antigenic test, SARS-CoV-2, self-sampling, diagnosis, mass screening, isolation measures, health education

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
10000 (Actual)

8. Arms, Groups, and Interventions

Arm Title
mass screening SARS-COV-19
Arm Type
Experimental
Arm Description
20 0000 participant will be included during mass screening SARS-COV-19 of the population of the city of Saint-Etienne. They will have two strategies both based on self-samples: (i) a saliva sample combined to an anterior nare self-swabbing tested by antigenic test versus (ii) a saliva sample tested by RT-PCR.
Intervention Type
Diagnostic Test
Intervention Name(s)
saliva sample combined to an anterior nare self-swabbing (Self-samples)
Intervention Description
Tested by antigenic test.
Intervention Type
Diagnostic Test
Intervention Name(s)
saliva sample (Self-sample)
Intervention Description
Tested by RT-PCR.
Intervention Type
Other
Intervention Name(s)
Survey of SARS-COV-19 knowledge
Intervention Description
collection of : socio-professional characteristics, questions on health literacy on the transmission of the virus and barrier gestures, adherence to barrier gestures, isolation modalities in case of positivity, motivations for participating in this screening campaign.
Intervention Type
Other
Intervention Name(s)
Survey of acceptability of the different self-samples.
Intervention Description
collection of : assessment and acceptability of the tolerance of self-samples.
Primary Outcome Measure Information:
Title
Positivity of self-samples combining saliva and anterior nare specimens tested by rapid antigenic test compared to saliva tested by RT-PCR (gold-standard).
Description
Measured by antigenic test results and RT-PCR results.
Time Frame
Day: 7
Secondary Outcome Measure Information:
Title
Number and percentage of SARS-CoV-2 infection in the selected population tested by reference RT-PCR on saliva
Description
Measured by RT-PCR results.
Time Frame
Day: 7
Title
Number and percentage of the circulation of different variants of interest of SARS-CoV-2 viruses in the tested population
Description
Measured by RT-PCR results.
Time Frame
Day: 7
Title
Evaluate the acceptability (pain, discomfort, speed of execution) of self-samples according to age and socio-professional categories
Description
Measured by survey of acceptability of the different self-samples results.
Time Frame
Day: 7
Title
Evaluate the cost-effectiveness ratio of the new strategy by comparison to the gold standard (RT-PCR on saliva)
Description
Measured by number of test performed and performances of self-samples combining saliva and anterior nare specimens tested by rapid antigenic test compared to saliva tested by RT-PCR.
Time Frame
Day: 7
Title
Number of people who have benefited from sensitization and support specifically set up as part of the screening campaign
Description
Measured the screening day.
Time Frame
Day: 7
Title
Number of persons cared for by the territorial isolation support cell (CTAI)
Description
Measured the screening day.
Time Frame
Day: 7
Title
Health literacy questionnaire
Description
It is a questionnaire with items on the transmission of the virus and barrier gestures, adherence to barrier gestures, modalities of isolation in case of positivity and motivations for participating in this screening campaign.
Time Frame
Day: 7

10. Eligibility

Sex
All
Minimum Age & Unit of Time
10 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Adult age or at least 10 year old able to perform self-sampling of saliva and anterior nare swabbing Subject or legal tutor agreeing to participate to self-sampling and to collect anonymized data required by the present research Exclusion Criteria: Inability to understand the protocol (language barrier notably) Deny to participate to the proposed research Patients under tutorship
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Bruno POZZETTO, MD PhD
Organizational Affiliation
CHU Saint-Etienne
Official's Role
Principal Investigator
Facility Information:
Facility Name
CHU Saint-Etienne
City
Saint-Étienne
Country
France

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
35270262
Citation
Verot E, Bonjean P, Chaux R, Gagnaire J, Gagneux-Brunon A, Pozzetto B, Berthelot P, Botelho-Nevers E, Chauvin F. Development and Validation of the COVID-19 Knowledges and Behavior Questionnaire in a French Population (CoVQuest-CC). Int J Environ Res Public Health. 2022 Feb 23;19(5):2569. doi: 10.3390/ijerph19052569.
Results Reference
derived

Learn more about this trial

Comparison of Strategies Based on RT-PCR or Antigenic Test for the Screening of SARS-CoV-2 Infection (COVID-19).

We'll reach out to this number within 24 hrs